Does Vitamin D deficiency play a role in peripheral neuropathy in Type 2 diabetes?

Diabetic Medicine

Volumn 29, Issue 1, 2012, Pages 43-49

  Shehab, D ^a   Al Jarallah, K ^a   Mojiminiyi, O A ^a   Al Mohamedy, H ^b   Abdella, N A ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MUBARAK AL KABEER HOSPITAL   (Kuwait)

Author keywords

Peripheral neuropathy; Type 2 diabetes; Vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; ALBUMIN; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; VITAMIN D;

ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; SCORING SYSTEM; URINE LEVEL; VITAMIN D DEFICIENCY;

ALBUMINURIA; CHOLESTEROL, LDL; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISABILITY EVALUATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; VITAMIN D DEFICIENCY;

EID: 83155192743     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03510.x     Document Type: Article

References (25)

1. Carlson AN, Kenny AM. Is Vitamin D Insufficiency Associated With Peripheral Neuropathy? Endocrinologist 2007; 17: 319-324.
2. Sutherland M, Somerville M, Yoong L, Bergeron C, Haussler MR, McLachlan DR. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Mol Brain Res 1992; 13: 239-250.
3. Fernandes DA, Eyles D, Féron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009; 345: S265-S277.
4. Riaz S, Tomlinson DR. Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and beta(2)-adrenoceptor agonists. Brain Res Mol 2000; 85: 179-188.
5. 3 derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia 1999; 42: 1308-1313.
6. Isaia G, Giorgino R, Adami S. High prevalence of hypovitaminosis D female type 2 diabetic population. Diabetes Care 2001; 24: 1496.
7. Valensi P, Devehat C, Richard J, Farez C, Khodabandehlou T, Rosenbloom R et al. A multicenter double blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy: a preliminary report. J Diabetes Complications 2005; 19: 247-253.
8. Lee P, Chen R. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med 2008; 168: 771-772.
9. Young MJ, Boulton AJ, Macleod AF, William DR, Sonksen PH. A multicenter study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154.
10. Shehab D. Normative DATA of nerve conduction studies in the upper limb in Kuwait - are they different than the western data? Med Princ Pract 1998; 7: 203-208.
11. Shehab D, Moussa MA. Normal values of lower limb nerve conduction in Kuwait (Part II). Med Princ Pract 1999; 8: 134-137.
12. Perkins B, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 2001; 24: 250-256.
13. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010; 95: 471-478.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
15. Palomer X, González-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008; 10: 185-197.
16. Inomata S, Kadowaki S, Yamatani T, Fukase M, Fujita T. Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner 1986; 1: 187-192.
17. Alvarez JA, Ashraf A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010; 2010: 351-385.
18. Kaul K, Hodgkinson A, Tarr JM, Kohner EM, Chibber R. Is inflammation a common retinal-renal-nerve pathogenic link in diabetes? Curr Diabetes Rev 2010; 6: 294-303.
19. McCarty MF. Secondary hyperparathyroidism promotes the acute phase response: a rationale for supplemental vitamin D in prevention of vascular events in the elderly. Med Hypotheses 2005; 64: 1022-1026.
20. Boulton AJ, Malik RA. Diabetic neuropathy. Med Clin North Am 1998; 82: 909-929.
21. Abdella NA. Controversies in management of diabetes in patients with coronary heart disease. Med Princ Pract 2002; 11(Suppl 2): 69-74.
22. Mojiminiyi OA, Al Mulla F, Abdella NA. Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus? Med Princ Pract 2009; 18: 123-129.
23. Taylor AV, Wise PH. Vitamin D replacement in Asians with diabetes may increase insulin resistance. Postgrad Med J 1998; 74: 365-366.
24. Reis JP, Michos ED, von Mühlen D, Miller ER 3rd. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr 2008; 88: 1469-1477.
25. Ozfirat Z, Chowdhury TA. Vitamin D deficiency and type 2 diabetes. Postgrad Med J 2010; 86: 18-25.